Almac Diagnostics, EORTC Collaborate for Tumor Profiling
Almac Diagnostics has announced its selection by the EORTC as a partner for the molecular profiling of cancer patient samples.
CROS NT Acquires PM Clinical Division
CROS NT has announced the acquisition of the clinical division of PM Clinical Limited.
The Growing Role of Performance Incentives Between Sponsors, CROs
The expanding role of incentives is a healthy trend in an industry defined by high costs and the pressure of deadlines, and such agreements have evolved recently to benefit all involved.
Off-Label Use: It's Complicated!
A recently released study regarding off-label prescribing in Europe has caused confusion as it lacked clarity on how the issue of how to govern off-label use going forward.
Introduction to Cloud Computing for the Analysis of Large Human Datasets
The economics and power of the cloud will drive its increasing adoption by pharma organizations for the foreseeable future as research becomes more data-intensive.
European and U.S. Regulators Agree on Mutual Recognition of Inspections
Regulators in the European Union (EU) and the U.S. have agreed to recognize inspections of manufacturing sites for human medicines conducted in their respective territories on both sides of the Atlantic.
Frost & Sullivan Reveal Asia as Ideal Trial Destination
Frost & Sullivan have released a whitepaper, with Asia Pacific specialist CRO Novotech, revealing that Asia is becoming an ideal destination for clinical trials.
Is the European Union Going to Abandon Health Entirely?
The European Union, looking to re-invent itself in the wake of Brexit, is considering withdrawing policy in the field of public health.
PPD Awarded NIH Contract for HIV Research Support
PPD has announced that it has renewed its contract with the Division of Aids, National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH).
OmniComm, Bio-Optronics to Provide Solutions for Children's Cancer Center
Omnicomm Systems and Bio-Optronics have reached an agreement to integrate OmniComm’s TrialMaster EDC with Bio-Optronics CTMS solution for multiple facilities at a children’s health institution.
Packaging, IT and Cold-Chain Logistics Advances for the Future of Medicine and Clinical Trials
Logistics can have a direct and measurable scientific impact on development, clinical performance and commercialization success of advanced drug therapeutics.
How is Endpoint Adjudication Impacting Clin Ops? A Survey
This survey on Endpoint Adjudication evaluates how this concept is impacting study design, uncovering operational challenges and determining outcomes.
Rare Diseases Don't Feel So Rare to Me
With sixty million Americans and Europeans diagnosed with one or more of 7,000 defined rare diseases, the availability of treatments has been less than expected.
EFPIA Unveils Nathalie Moll as New Director General
The EFPIA has revealed the appointment of Nathalie Moll as its new director general.
Worldwide Creates New Fellowship Program
PPD Introduces Rare Disease and Pediatric Center
PPD has established a Rare Disease and Pediatric Center to oversee rare disease and pediatric-related drug development activities.
Worldwide Clinical Trials has announced the creation of its new Michael F. Murphy Clinical Research Methodology Fellowship Program.
Where’s the Exit? An Update on Brexit
With the U.K. poised to begin the process of leaving the European Union soon, many questions remain as to the specifics of pharma regulation and the wide-ranging effects of this departure.
TrialScope Launches Trial Results Summaries Portal
TrialScope announced the launch of the Trial Results Summaries Portal, developed in partnership with AstraZeneca.
ERT Clinical Trial Oversight Selected by Premier Research
ERT announced that clinical development service provider, Premier Research, has selected ERT’s Trial Oversight suite as its trial management solution.
Uphill Work to Realize Dreams of Rare Disease Treatment
The Belgium-based EURORDIS symposium on rare diseases set out to realize dreams of accessible treatment for all, but the first day left much to be desired for this achievement.
PPD Collaborates with Frenova
TransCelerate Launches Quantitative Metrics Toolkit and Discusses RBM Advancement
Justin Stark, Head and Director of Risk-based Monitoring and Standards are UCB discusses advancements in RBM and TransCelerate’s Quantitative Metrics Toolkit.
